These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 17574978)

  • 1. Noninvasive assessment of Crohn's disease intestinal lesions with (18)F-FDG PET/CT.
    Louis E; Ancion G; Colard A; Spote V; Belaiche J; Hustinx R
    J Nucl Med; 2007 Jul; 48(7):1053-9. PubMed ID: 17574978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG PET/CT in Crohn's disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity.
    Saboury B; Salavati A; Brothers A; Basu S; Kwee TC; Lam MG; Hustinx R; Louis E; Torigian DA; Alavi A
    Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):605-14. PubMed ID: 24253895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [
    Chen L; Zhong X; Li L; Li X; Liu Y; Guo C; Chen Y; Huang Z
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1360-1370. PubMed ID: 36631715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings.
    Sipponen T; Savilahti E; Kolho KL; Nuutinen H; Turunen U; Färkkilä M
    Inflamm Bowel Dis; 2008 Jan; 14(1):40-6. PubMed ID: 18022866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
    Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of disease location on fecal calprotectin levels in Crohn's disease.
    Gecse KB; Brandse JF; van Wilpe S; Löwenberg M; Ponsioen C; van den Brink G; D'Haens G
    Scand J Gastroenterol; 2015 Jul; 50(7):841-7. PubMed ID: 25636819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-Fluorodeoxyglucose positron-emission tomography (PET) can be used to assess inflammation non-invasively in Crohn's disease.
    Holtmann MH; Uenzen M; Helisch A; Dahmen A; Mudter J; Goetz M; Schreckenberger M; Galle PR; Bartenstein P; Neurath MF
    Dig Dis Sci; 2012 Oct; 57(10):2658-68. PubMed ID: 22569824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum calprotectin as a biomarker for Crohn's disease.
    Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
    J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.
    Lobatón T; López-García A; Rodríguez-Moranta F; Ruiz A; Rodríguez L; Guardiola J
    J Crohns Colitis; 2013 Dec; 7(12):e641-51. PubMed ID: 23810085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose 18F-FDG PET/CT enterography: improving on CT enterography assessment of patients with Crohn disease.
    Shyn PB; Mortele KJ; Britz-Cunningham SH; Friedman S; Odze RD; Burakoff R; Goldberg JE; Erturk M; Silverman SG
    J Nucl Med; 2010 Dec; 51(12):1841-8. PubMed ID: 21078803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG positron emission tomography: potential utility in the assessment of Crohn's disease.
    Shyn PB
    Abdom Imaging; 2012 Jun; 37(3):377-86. PubMed ID: 21833729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of [
    Li Z; Chen Z; Zhang R; Lin J; Huang S; Shi K; Shen X; Xiang Z; Wang X; Huang L; Zheng Q; Liu X; Tan J; Chen M; Li Z; Mao R; Zhang X; Wang Y; Song X; Li X
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1856-1868. PubMed ID: 38355741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
    Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
    Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of FDG PET-CT in the characterization of the activity of Crohn's disease, staging follow-up and prognosis estimation: a pilot study.
    Palatka K; Kacska S; Lovas S; Garai I; Varga J; Galuska L
    Scand J Gastroenterol; 2018 Jan; 53(1):24-30. PubMed ID: 29043862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Positron Emission Tomography in Assessing Disease Activity in Ulcerative Colitis: Comparison with Biomarkers.
    Berry N; Sinha SK; Bhattacharya A; Prasad KK; Vaishnavi C; Vaiphei K; Samanta J; Prasada R; Dhaka N; Kochhar R
    Dig Dis Sci; 2018 Jun; 63(6):1541-1550. PubMed ID: 29564671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of 18F-FDG PET/MRE Metrics with Inflammatory Biomarkers in Patients with Crohn's Disease: A Pilot Study.
    Domachevsky L; Leibovitzh H; Avni-Biron I; Lichtenstein L; Goldberg N; Nidam M; Groshar D; Bernstine H; Ben-Bassat O
    Contrast Media Mol Imaging; 2017; 2017():7167292. PubMed ID: 29097934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
    Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational 18F-FDG PET/CT imaging to monitor lesion activity in intestinal inflammation.
    Bettenworth D; Reuter S; Hermann S; Weckesser M; Kerstiens L; Stratis A; Nowacki TM; Ross M; Lenze F; Edemir B; Maaser C; Pap T; Koschmieder S; Heidemann J; Schäfers M; Lügering A
    J Nucl Med; 2013 May; 54(5):748-55. PubMed ID: 23516311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/CT enterography in Crohn disease: correlation of disease activity on CT enterography with 18F-FDG uptake.
    Groshar D; Bernstine H; Stern D; Sosna J; Eligalashvili M; Gurbuz EG; Niv Y; Fraser G
    J Nucl Med; 2010 Jul; 51(7):1009-14. PubMed ID: 20554741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Level of Fecal Calprotectin Correlates With Severity of Small Bowel Crohn's Disease, Measured by Balloon-assisted Enteroscopy and Computed Tomography Enterography.
    Arai T; Takeuchi K; Miyamura M; Ishikawa R; Yamada A; Katsumata M; Igarashi Y; Suzuki Y
    Clin Gastroenterol Hepatol; 2017 Jan; 15(1):56-62. PubMed ID: 27565523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.